Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Artelo Biosciences Inc WT (ARTLW)

Artelo Biosciences Inc WT (ARTLW)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0056 +0.0005 (+9.80%) 06/17/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.0056 unch (unch) -
Profile for Mon, Jun 17th, 2024

Company Info

Artelo Biosciences Inc WT 505 LOMAS SANTA FE SUITE 160 SOLANA BEACH CA 92075 USA

www.artelobio.com P: 858-925-7049

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Artelo Biosciences Inc. is a biopharmaceutical company. It is engaged in development and commercialization of proprietary therapeutics targeting the endocannabinoid system. The company's product pipeline consists of ART27.13, ART12.11 and ART26.12 which are in clinical stage. Artelo Biosciences Inc. is based in La Jolla, CA.

Key Statistics

Overview:

Annual Sales, $ 0 K
Annual Net Income, $ -9,830 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,778 K
Short Volume Ratio 1.00

Growth:

1-Year Return -93.78%
3-Year Return -98.13%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date 05/12/25 [--]
EPS Growth vs. Prev Qtr -234.29%
EPS Growth vs. Prev Year -18.18%
Dividend Payout Ratio 0.00%

ARTLW Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity 0.02
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective